Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hernandez

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Microbiome|May 27, 2021
Characterization of the public transit air microbiome and resistome reveals geographical specificityM H Y Leung, X Tong, K O Bøifot, et al.
British Journal of Haematology|October 15, 2013
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA studyJoaquin Martinez-Lopez, Elena Fernández-Redondo, Ramón García-Sánz, et al.
Nature Microbiology|January 11, 2022
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, CaliforniaVenice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, et al.
Blood|December 16, 2015
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysisBruno Paiva, María Victoria Mateos, Luis Ignacio Sanchez-Abarca, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Leukemia|November 4, 2017
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trialsP Arana, B Paiva, M-T Cedena, et al.
Microbiome|August 29, 2025
Global biogeography of airborne viruses in public transit systems and their host interactionsHuaxin Lei, Shicong Du, Xinzhao Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2017
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical TrialsJuan-Jose Lahuerta, Bruno Paiva, Maria-Belen Vidriales, et al.
Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
Blood|January 13, 2016
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistanceBruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Microbiome|May 27, 2021
Characterization of the public transit air microbiome and resistome reveals geographical specificityM H Y Leung, X Tong, K O Bøifot, et al.
British Journal of Haematology|October 15, 2013
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA studyJoaquin Martinez-Lopez, Elena Fernández-Redondo, Ramón García-Sánz, et al.
Nature Microbiology|January 11, 2022
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, CaliforniaVenice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, et al.
Blood|December 16, 2015
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysisBruno Paiva, María Victoria Mateos, Luis Ignacio Sanchez-Abarca, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Leukemia|November 4, 2017
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trialsP Arana, B Paiva, M-T Cedena, et al.
Microbiome|August 29, 2025
Global biogeography of airborne viruses in public transit systems and their host interactionsHuaxin Lei, Shicong Du, Xinzhao Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2017
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical TrialsJuan-Jose Lahuerta, Bruno Paiva, Maria-Belen Vidriales, et al.
Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
Blood|January 13, 2016
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistanceBruno Paiva, Luis A Corchete, Maria-Belen Vidriales, et al.
Pageof 21